107 related articles for article (PubMed ID: 21320496)
1. Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1.
Sato M; Maruoka M; Yokota N; Kuwano M; Matsui A; Inada M; Ogawa T; Ishida-Kitagawa N; Takeya T
FEBS Lett; 2011 Mar; 585(6):834-40. PubMed ID: 21320496
[TBL] [Abstract][Full Text] [Related]
2. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion.
Maruoka M; Sato M; Yuan Y; Ichiba M; Fujii R; Ogawa T; Ishida-Kitagawa N; Takeya T; Watanabe N
Biochem J; 2012 Feb; 441(3):889-99. PubMed ID: 22014333
[TBL] [Abstract][Full Text] [Related]
3. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
[TBL] [Abstract][Full Text] [Related]
4. NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation.
Hirao N; Sato S; Gotoh T; Maruoka M; Suzuki J; Matsuda S; Shishido T; Tani K
FEBS Lett; 2006 Nov; 580(27):6464-70. PubMed ID: 17101133
[TBL] [Abstract][Full Text] [Related]
5. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
6. Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation.
Leng Y; Zhang J; Badour K; Arpaia E; Freeman S; Cheung P; Siu M; Siminovitch K
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1098-103. PubMed ID: 15657136
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oda T; Kujovich J; Reis M; Newman B; Druker BJ
Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
11. c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles.
Machuy N; Campa F; Thieck O; Rudel T
J Mol Biol; 2007 Jul; 370(4):620-32. PubMed ID: 17543336
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective Abelson kinase: requirements of myristoylation and src homology 3 domain.
Fujita A; Shishido T; Yuan Y; Inamoto E; Narumiya S; Watanabe N
Mol Pharmacol; 2009 Jan; 75(1):75-84. PubMed ID: 18835981
[TBL] [Abstract][Full Text] [Related]
13. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
14. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
Van Etten RA; Debnath J; Zhou H; Casasnovas JM
Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
[TBL] [Abstract][Full Text] [Related]
15. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase.
Tani K; Sato S; Sukezane T; Kojima H; Hirose H; Hanafusa H; Shishido T
J Biol Chem; 2003 Jun; 278(24):21685-92. PubMed ID: 12672821
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
18. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
Fan PD; Cong F; Goff SP
Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
[TBL] [Abstract][Full Text] [Related]
19. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
[TBL] [Abstract][Full Text] [Related]
20. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
de Jong R; van Wijk A; Heisterkamp N; Groffen J
Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
